MacroGenics Presents Results from the SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing